Yamaguchi S, Shimabukuro M, Tanaka A, Imai T, et al. Canagliflozin reduces proteinuria by targeting hyperinsulinemia in diabetic patients with heart failure: a post-hoc analysis of the CANDLE trial. Diabetes Obes Metab 2022 Oct 4. doi: 10.1111/dom.14876.
PMID: 36193841